Preventive Treatment of Groin Pain in Football

Sponsor

Universita degli Studi di Genova (Other)

Overall Status

Completed

CT.gov ID

NCT05713487

Collaborator

(none)

Enrollment

Location

Arms

11.3

Actual Duration (Months)

3.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Groin pain represents a common issue in football. Currently, there are no prevention protocols demonstrating real effectiveness. We aimed to investigate the possible positive effect of a prevention program for groin pain.Forty-two élite male athletes belonging to a youth academy of a professional football club were recruited in this prospective, randomized, controlled, single-blind, study.

Condition or Disease	Intervention/Treatment	Phase
Healthy	Other: preventive treatment group	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

42 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Investigator)

Primary Purpose:

Prevention

Official Title:

Preventive Treatment of Groin Pain Syndrome in élite Young Football Player: a Pilot Study

Actual Study Start Date :

Jan 10, 2022

Actual Primary Completion Date :

May 20, 2022

Actual Study Completion Date :

Dec 20, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: preventive treatment group	Other: preventive treatment group each athlete belonging to the preventive treatment group performed the protocol of preventive treatment 2 times a week, before or after the training session for five months
No Intervention: control group

Arm

Intervention/Treatment

Experimental: preventive treatment group

Other: preventive treatment group

each athlete belonging to the preventive treatment group performed the protocol of preventive treatment 2 times a week, before or after the training session for five months

No Intervention: control group

Outcome Measures

Primary Outcome Measures

Strength in the adductors [One day before the start of the physical protocol and one day after the end of the physical protocol]
The strength was evaluated in Newton during maximal voluntary isometric contraction used a dynamometer (Activforce 2)

Secondary Outcome Measures

Pain in the hip joint [One day before the start of the physical protocol and one day after the end of the physical protocol]
The pain was rated using the Numeric Pain Rating Scale (NPRS) (0-10; 0 represents no pain and 10 represents maximum pain) during maximal voluntary isometric contraction (Copenhagen five-second squeeze test).
Groin pain [One day before the start of the physical protocol and one day after the end of the physical protocol]
The pain was rated using the Numeric Pain Rating Scale (NPRS) (0-10; 0 represents no pain and 10 represents maximum pain) during maximal voluntary isometric contraction (Copenhagen five-second squeeze test).
Range of motion (ROM) of the hip joint [One day before the start of the physical protocol and one day after the end of the physical protocol]
ROM was assessed using the distance (cm) from the head of the fibula to the edge of the bed (Bent Knee Fall Out Test)

Eligibility Criteria

Criteria

Ages Eligible for Study:

16 Years to 18 Years

Sexes Eligible for Study:

Male

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

subjects between the ages of sixteen and eighteen, belonging to the youth sector of a professional club.

Exclusion Criteria:

Presence of pain or injuries at the level of the hip-hip region at the initial assessment.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Università degli Studi di Genova	Genova		Italy	16122

Sponsors and Collaborators

Universita degli Studi di Genova

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Luca Puce, principal investigator, Universita degli Studi di Genova

ClinicalTrials.gov Identifier:

NCT05713487

Other Study ID Numbers:

GP-DINOGMI-23

First Posted:

Feb 6, 2023

Last Update Posted:

Feb 6, 2023

Last Verified:

Feb 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Luca Puce, principal investigator, Universita degli Studi di Genova

Groin injuries, soccer, athletes, pain, muscle strength

Study Results

No Results Posted as of Feb 6, 2023